Trimethoprim-sulfamethoxazole. Summary and comments on the conference.
D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy; D002353:Carrier State / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D004357:Drug Synergism; D005260:Female; D006069:Gonorrhea / Q000188:drug therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000188:drug therapy; D013420:Sulfamethoxazole / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D013763:Tetrahydrofolates / Q000037:antagonists & inhibitors; D014295:Trimethoprim / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D014552:Urinary Tract Infections / Q000188:drug therapy
D004338:Drug Combinations; D013763:Tetrahydrofolates; D014295:Trimethoprim; D013420:Sulfamethoxazole